GENE ONLINE|News &
Opinion
Blog

Editors' Picks
COVID-19 mRNA Vaccine
Sanofi Abandons mRNA-Based COVID-19 Vaccine Plan but Indian Biotechs March On
2021-09-28
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Special Gene Therapy
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Funding
Jennifer Doudna’s Gene Editing Firm Mammoth Biosciences Attains Unicorn Status
2021-09-11
Licensing RNA Editing
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Novel Mutational Patterns Explain Evolution of Lung Cancer in Never-Smokers
2021-09-09
COVID-19 Mu Variant
Mu COVID Variant Could Potentially Escape Immunity But Delta is Still “Most Concerning”, WHO Says
2021-09-08
Licensing
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
COVID-19 DNA Vaccine
Why Are Human DNA Vaccines Such a Big Deal?
2021-09-02
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Technology Targeted Protein Degrader
Eli Lilly, Lycia Partnership Signifies the Growing Targeted Protein Degradation Market
2021-08-27
Interviews RNA Editing
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
Interviews RNA Editing
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Deals RNA Editing
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
1 … 6 7 8 9 10 … 13
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top